FDA statement By Anna Rodet | March 23, 2020 FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic Download Posted in Recent News ← EMA statementIFAPP’s recommendation in combatting COVID-19 →